Towards a better understanding of the clinical association of anti-DFS70 autoantibodies

Autoimmunity Reviews

Volumn 15, Issue 2, 2016, Pages 198-201

  Mahler, Michael ^a   Meroni, Pier Luigi ^b   Andrade, Luis E ^c   Khamashta, Munther ^d   Bizzaro, Nicola ^e   Casiano, Carlos A ^f   Fritzler, Marvin J ^g  

^a INOVA DIAGNOSTICS INC   (United States)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e San Antonio Hospital   (Italy)

^f LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALGARY   (Canada)

Author keywords

Antinuclear antibodies; Autoantibodies; Autoimmune diseases; DFS; LEDGF

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; DFS70 AUTOANTIBODY; UNCLASSIFIED DRUG; PSIP1 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

ANTIBODY DETECTION; ATOPIC DERMATITIS; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; HUMAN; PREVALENCE; REVIEW; THROMBOSIS; IMMUNOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; AUTOIMMUNE DISEASES; HUMANS; TRANSCRIPTION FACTORS;

EID: 84954365915     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.11.006     Document Type: Review

References (26)

1. Mahler M., Hanly J.G., Fritzler M.J. Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases. Autoimmun Rev 2011, 11:642-645.
2. Mahler M., Fritzler M.J. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol 2012 2012, 494356.
3. Ganapathy V., Casiano C.A. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us?. Arthritis Rheum 2004, 50:684-688.
4. Marlet J., Ankri A., Charuel J.L., Ghillani-Dalbin P., Perret A., Martin-Toutain I., et al. Thrombophilia associated with anti-DFS70 autoantibodies. PLoS One 2015, 10.
5. Ochs R.L., Stein T.W., Peebles C.L., Gittes R.F., Tan E.M. Autoantibodies in interstitial cystitis. J Urol 1994, 151:587-592.
6. Ochs R.L., Mahler M., Basu A., Rios-Colon L., Sanchez T.W., Andrade L.E., et al. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med 2015, (in press).
7. Agmon-Levin N., Damoiseaux J., Kallenberg C., Sack U., Witte T., Herold M., et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 2013, 73:17-23.
8. Mahler M., Fritzler M.J. Epitope specificity and significance in systemic autoimmune diseases. Ann N Y Acad Sci 2010, 1183:267-287.
9. Meroni P.L., Schur P.H. ANA screening: an old test with new recommendations. Ann Rheum Dis 2010, 69:1420-1422.
10. Mariz H.A., Sato E.I., Barbosa S.H., Rodrigues S.H., Dellavance A., Andrade L.E. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum 2011, 63:191-200.
11. Watanabe A., Kodera M., Sugiura K., Usuda T., Tan E.M., Takasaki Y., et al. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum 2004, 50:892-900.
12. Muro Y., Sugiura K., Morita Y., Tomita Y. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus 2008, 17:171-176.
13. Bizzaro N., Tonutti E., Villalta D. Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEP-2 cells: not an easy task! Comment on the article by Mariz et al. Arthritis Rheum 2011, 63:4036-4037.
14. Bizzaro N., Tonutti E., Tampoia M., Infantino M., Cucchiaro F., Pesente F., et al. Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence. Clin Chim Acta 2015, 451:271-277.
15. Miyara M., Albesa R., Charuel J.L., El A.M., Fritzler M.J., Ghillani-Dalbin P., et al. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort. Clin Dev Immunol 2013 2013, [703759].
16. Basu A., Woods-Burnham L., Ortiz G., Rios-Colon L., Figueroa J., Albesa R., et al. Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clin Immunol 2015, 161:241-250.
17. Hiemann R., Buttner T., Krieger T., Roggenbuck D., Sack U., Conrad K. Challenges of automated screening and differentiation of non-organ specific autoantibodies on HEp-2 cells. Autoimmun Rev 2009, 9:17-22.
18. Bizzaro N., Antico A., Platzgummer S., Tonutti E., Bassetti D., Pesente F., et al. Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev 2014, 13:292-298.
19. Bhattacharyya R., Mukherjee K., Das A., Biswas M.R., Basunia S.R., Mukherjee A. Anti-thyroid peroxidase antibody positivity during early pregnancy is associated with pregnancy complications and maternal morbidity in later life. J Nat Sci Biol Med 2015, 6:402-405.
20. Tincani A., Rebaioli C.B., Frassi M., Taglietti M., Gorla R., Cavazzana I., et al. Pregnancy and autoimmunity: maternal treatment and maternal disease influence on pregnancy outcome. Autoimmun Rev 2005, 4:423-428.
21. Rodriguez-Garcia J.L., Bertolaccini M.L., Cuadrado M.J., Sanna G., Ateka-Barrutia O., Khamashta M.A. Clinical manifestations of antiphospholipid syndrome (APS) with and without antiphospholipid antibodies (the so-called 'seronegative APS'). Ann Rheum Dis 2012, 71:242-244.
22. Cervera R., Conti F., Doria A., Iaccarino L., Valesini G. Does seronegative antiphospholipid syndrome really exist?. Autoimmun Rev 2012, 11:581-584.
23. Sanmarco M. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome". Autoimmun Rev 2009, 9:90-92.
24. Fatma N., Singh D.P., Shinohara T., Chylack L.T. Heparin's roles in stabilizing, potentiating, and transporting LEDGF into the nucleus. Invest Ophthalmol Vis Sci 2000, 41:2648-2657.
25. Schmeling H., Mahler M., Levy D.M., Moore K., Stevens A.M., Wick J., et al. Autoantibodies to dense fine speckles in pediatric diseases and controls. J Rheumatol 2015, (in press).
26. Muro Y., Sugiura K., Nakashima R., Mimori T., Akiyama M. Low prevalence of anti-DFS70/LEDGF antibodies in patients with dermatomyositis and other systemic autoimmune rheumatic diseases. J Rheumatol 2013, 40:92-93.